Related Experiment Video
Updated: Jun 23, 2026

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
Published on: December 21, 2019
Future developments in the management of malignant pleural mesothelioma
Paolo Andrea Zucali1, Fabio De Vincenzo, Matteo Simonelli
1Department of Medical Oncology, Istituto Clinico Humanitas, Via Manzoni 56, 20089 Rozzano, Milan, Italy. paolo.zucali@humanitas.it
Abstract:
Malignant pleural mesothelioma (MPM) is an aggressive tumor with a poor prognosis and an increasing incidence as a result of widespread exposure to asbestos. In the past few years, there have been several developments in the management of patients with MPM, including more accurate staging and patient selection, improvements in surgical techniques and postoperative care, novel chemotherapy regimens and new radiotherapy techniques. However, chemotherapy remains the mainstay of treatment, considering that surgery and radiotherapy have a limited role in highly selected patients, and its results are still modest, with a median survival of approximately 1 year. The principal goals of this review are to summarize the improvements in the management of MPM that have been achieved recently and to outline the therapeutic approaches in development.
Insights
Malignant pleural mesothelioma (MPM) is an aggressive asbestos-related cancer. Recent advances in staging, surgery, and chemotherapy offer modest survival improvements, with new treatments under development.
Area of Science:
- Oncology
- Thoracic Surgery
- Pulmonology
Background:
- Malignant pleural mesothelioma (MPM) is an aggressive cancer linked to asbestos exposure.
- MPM has a poor prognosis and increasing incidence globally.
- Current treatments offer limited survival benefits, with a median survival of about one year.
Purpose of the Study:
- To review recent advancements in MPM management.
- To outline emerging therapeutic strategies for MPM.
- To provide an overview of current and future MPM treatment options.
Main Methods:
- Literature review of recent studies on MPM management.
- Analysis of improvements in staging, surgical techniques, and adjuvant therapies.
- Evaluation of novel chemotherapy regimens and radiotherapy techniques.
Main Results:
- Improved patient selection and surgical outcomes have been noted.
- Novel chemotherapy regimens show modest survival benefits.
- Radiotherapy techniques have advanced, but their role remains limited.
Conclusions:
- Chemotherapy is the primary treatment for MPM, despite modest results.
- Recent advancements have improved MPM patient management.
- Ongoing research focuses on developing more effective therapeutic approaches for MPM.
Related Concept Videos
Pleural Disorders: Types and Brief Description
Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
Pneumothorax-II
Clinical Manifestations:
Endoscopic Studies I: Bronchoscopy and Thoracoscopy
Bronchoscopy
Description
Bronchoscopy is a procedure that involves direct visualization of the larynx, trachea, and bronchi for diagnostic and therapeutic purposes. A flexible fiber optic or rigid bronchoscope is used to carry out the procedure. The fiber-optic bronchoscope is more frequently used due to...
Pulmonary Embolism III: Nursing Management

